Amy Gravino is a certified autism specialist and professional public speaker and writer whose work focuses on sex and sexuality among autistic people. As founder and president of A.S.C.O.T. Consulting, she offers autism consulting and college coaching services for individuals on the spectrum, mentoring services for young adults with autism, and professional presentations for conferences, autism events, schools and professional development workshops. She has an M.A. in applied behavior analysis from Caldwell University in New Jersey. Gravino is working on a book, “The Naughty Autie,” a memoir of her experiences with relationships as a woman on the autism spectrum.
Amy Gravino
Autism consultant
From this contributor
Why it’s time to be honest about autistic women and sex
Misinformation about autistic women and sex is common in the scientific community. A study published this year is a case in point.
Why it’s time to be honest about autistic women and sex
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.